Autologous Cell-Enriched Fat Grafting for Breast Augmentation
Autologous fat grafting for breast augmentation has faced some historical hurdles. However, in recent years it has been gaining acceptance from the medical community. This prospective, nonrandomized open-label study of 20 Japanese women supports the use of autologous fat grafting in breast augmentation and explores enhancement of fat graft tissue with autologous adipose-derived regenerative cells (ADRCs). After adipose harvesting using syringe liposuction, the tissue is processed in the Celution 800 System®, which washes the graft and isolates ADRCs. The average cells per gram of harvested adipose tissue was 3.42 × 105, and the mean cell viability measured using an automated cell counting system before graft delivery was 85.3%. All patients demonstrated improvement in circumferential breast measurement (BRM) from their baseline state, and breast measurements were stable by 3 months after surgery. The mean BRM 9 months after surgery had increased 3.3 cm from preoperative measurements. Through 9 months, overall physician satisfaction was 69% and patient satisfaction was 75%. No serious or unexpected adverse events were reported, and the procedure was safe and well tolerated in all patients. Postoperative cyst formation was seen in two patients. These prospective results demonstrate that ADRC-enriched fat grafts processed with a closed automated system maintain high cell viability and that the procedure is safe and effective, with all patients showing improvement after a single treatment.
KeywordsAdipose-derived regenerative cells Adipose tissue graft Autologous fat graft Breast augmentation Cell-enriched graft Celution Stem cells
Editorial assistance and technical support for the Celution 800 System® were provided by Cytori Therapeutics. The authors have no other conflicts of interest and did not receive any other support, financial or otherwise, from Cytori Therapeutics.
Conflict of interest
The authors have no other conflicts of interest and did not receive any other support, financial or otherwise, from Cytori Therapeutics.
- 1.Czerny V (1895) Plastischer Ersatz der Brusthus durch ein Lipoma. Zentralbl Chir 27:72Google Scholar
- 6.Toledo LS, Mauad R (2006) Fat injection: a 20-year revision. Clin Plast Surg 33:47–53, viGoogle Scholar
- 7.Butterwick KJ, Nootheti PK, Hsu JW, Goldman MP (2007) Autologous fat transfer: an in-depth look at varying concepts and techniques. Facial Plast Surg Clin North Am 15:99–111, viiiGoogle Scholar
- 8.Yoshimura K, Shigeura T, Matsumoto D, Sato T, Takaki Y, Aiba-Kojima E, Sato K, Inoue K, Nagase T, Koshima I, Gonda K (2006) Characterization of freshly isolated and cultured cells derived from the fatty and fluid portions of liposuction aspirates. J Cell Physiol 208:64–76PubMedCrossRefGoogle Scholar
- 13.Planat-Benard V, Silvestre JS, Cousin B, Andre M, Nibbelink M, Tamarat R, Clergue M, Manneville C, Saillan-Barreau C, Duriez M, Tedgui A, Levy B, Penicaud L, Casteilla L (2004) Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation 109:656–663PubMedCrossRefGoogle Scholar
- 18.Kitamura K, Mori M, Sugimachi K (2007) Stem cell augmented reconstruction: a new hope for reconstruction after breast conservation therapy (abstract). Breast Cancer Res Treat 106(Supp1):4071Google Scholar
- 27.Rigotti G, Marchi A, Montemezzi S et al (2008) Lipoaspirate transplant to treat breast conservative treatment side effects: evaluation of the risk to develop calcifications. In: Presented at the 87th annual American association of plastic surgeons (AAPS), meeting and aesthetic symposium, 5–8 April 2008Google Scholar